Description
From the Creator of Toxic Psychiatry and Talking Back to Prozac:
Peter Breggin is the sense of right and wrong of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, in addition to patients and families.”
“Nowhere does false medical thinking do more harm than in the modern psychiatric argument that mental illness is easily diagnosed and then cured by a side-effect free drug. Nowhere is the right kind psychiatric thinking more evident than in the books by Peter Breggin.
In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote.
Many of Breggin’s earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers should admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice.
This greatly expanded second edition, supported by the up to date evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they have a tendency to do far more harm than good.
- New scientific analyses in this completely up to date edition include:
- Chapters covering every new antidepressant and stimulant drug
- Twenty new guidelines for how to conduct non-drug therapy
- A chapter describing how to safely withdraw from psychiatric drugs
- A discussion of “medication spellbinding,” explaining how patients fail to appreciate their drug-induced mental dysfunctions
- Documentation of how the drug companies keep watch over research and the glide of information about psychiatric treatments